200 filings
Page 5 of 10
6-K
50v6sn kvr07
6 Aug 21
Current report (foreign)
7:48am
20-F/A
etl2tig6phd
6 Aug 21
Annual report (foreign) (amended)
7:46am
6-K
lpu8bi3fvzu9vkvpy
14 Jul 21
Current report (foreign)
6:04am
6-K
ilg8hyahffdqt pu
11 May 21
Aslan Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
8:13am
6-K
636t44lvwv
22 Apr 21
Aslan Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
2:20pm
EFFECT
sw5vy0e2ms5
1 Apr 21
Notice of effectiveness
12:16am
CORRESP
xmg75x 9s8t
31 Mar 21
Correspondence with SEC
12:00am
UPLOAD
nqic4v znxm0jcn6
31 Mar 21
Letter from SEC
12:00am
F-3
bph0do
26 Mar 21
Shelf registration (foreign)
4:18pm
6-K
5f2xkmnq e61qiq8
18 Mar 21
Current report (foreign)
7:30am
6-K
h7ix1 4r0whwma
4 Mar 21
Aslan Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares
6:07am
424B5
52gy45l
4 Mar 21
Prospectus supplement for primary offering
6:06am
424B5
tlyz1796fh v06gc1r
1 Mar 21
Prospectus supplement for primary offering
5:08pm
6-K
rpyuo064imhz 8bso1hs
1 Mar 21
Current report (foreign)
4:02pm
6-K
hqqxsca6x q3b17
1 Mar 21
Current report (foreign)
6:32am
6-K
y1j0zzqx
25 Feb 21
Current report (foreign)
7:01am
6-K
5algnj5fee35mjidhi
18 Feb 21
Current report (foreign)
7:15am
EFFECT
siiio8qjvmmxxqtn9
12 Feb 21
Notice of effectiveness
12:15am
SC 13G/A
sj4fpjlikgbhvk y7951
11 Feb 21
ASLAN Pharmaceuticals / Temasek Holdings ownership change
6:04am